期刊文献+

血清25羟基维生素D水平与糖代谢异常的关系探讨 被引量:6

The study on relationship between serum 25-hydroxyvitamin D and abnormal glucose metabolism
下载PDF
导出
摘要 目的:探讨人群不同糖代谢状态与血清25羟基维生素D[25(OH)D]水平的相关关系。方法:采用横断面调查研究,对2008—2014年于深圳市南山区人民医院体检的300例成年人进行口服葡萄糖耐量试验(OGTT),将其分为6组:正常糖耐量(NGT)组、空腹血糖受损(IFG)组、1h高血糖(1hHPG)组、糖耐量异常(IGT)组、IFG合并IGT组及2型糖尿病(T2DM)组,每组50例。检测一般生化指标、空腹血糖(FPG)及糖负荷后0.5h、1h、2h、3h血糖、真胰岛素(FTI),计算糖负荷后0.5h胰岛素增量与葡萄糖增量的比值(△I30/△G30)、稳态模型胰岛素抵抗指数(HOMA-IR)、胰岛β细胞功能指数(HBCI)、校正胰岛素抵抗后的胰岛β细胞功能(HBCI/IR),分析血清25(OH)D水平与糖代谢的关系。结果:6组血清25(OH)D水平比较差异具有统计学意义(F=2.43,P=0.035);其中NGT组血清25(OH)D水平最高,T2DM组最低。校正年龄、性别、体重指数(Ibm)等因素后,25(OH)D与FPG、糖负荷后各时间点(1h、2h、3h)血糖、糖化血红蛋白(HbA1c)呈负相关关系(r=-0.221、-0.223、-0.224、-0.231、-0.191,均P<0.05),与HBCI/IR呈正相关关系(r=0.205,P<0.01)。多因素Logistic回归分析结果显示25(OH)D是糖代谢异常的保护因素(P<0.05)。结论:血清25(OH)D水平与血糖水平呈负相关关系,是糖代谢异常的保护因素。 Objective. To investigate the relationship between different glucose metabolism and serum level of 25-hydroxyvitamin D 1-25 (OH) D]. Methods: By cross-sectional study, subjects were selected from physical examination in Nanshan hospital of Shenzhen from 2008-2014, following 75 g oral glucose tolerance test (OGTT), and divided into six groups: normal glucose tolerance (NGT), impaired fasting glucose (IFG), 1 h hyperglycemia (1 h HPG), impaired glucose tolerance (IGT), IFG combined with IGT, and type 2 diabetes mellitus (T2DM) groups, 50 cases in each group. Fasting blood-glucose (FPG) and post glucose load 0.5 h, 1 h, 2 h, 3 h plasma glucose, and true insulin levels were measured. △I30/△G30, HOMA-IR, HBCI and HBCI/IR were calculated accordingly to evaluate islet function. The relationship between 25 (OH) D and glucose metabo lism was analyzed. Results: The differences of serum 25 (OH) D among the six groups were significant (P d0.05). The NGT group exerted the highest level of 25(OH) D, while the T2DM group were found to have the lowest level of 25(OH)D. Adjusted for age, sex and body mass index, the level of 25(OH)Dwas negatively correlated to FPG, glycosylated hemoglobin and blood glucose level after OGTT(r= 0. 221, -0. 223, -0. 224, -0. 231 and -0. 191 ,All P〈0.05), and was positively correlated to HBCI/IR(r=0. 205, P〈0.01). Multivariate logistic regression analysis showed that 25 (OH)D was independent protective factor for the occurrence of abnormal glucose (P〈0.05). Conclusion: The level of 25(OH)D was negatively correlated to the blood glucose level, and 25(OH)D was independent protective factor for the occurrence of abnormal glucose.
出处 《广西医科大学学报》 CAS 2017年第7期1023-1026,共4页 Journal of Guangxi Medical University
基金 深圳市卫生计生系统科研课题资助项目(No.201402136)
关键词 25羟维生素D 1h高血糖 真胰岛素 胰岛功能 糖代谢异常 25(()H)D 1 h hyperglycemia true insulin islet function abnormal glucose metabolism
  • 相关文献

参考文献1

二级参考文献10

  • 1Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia, 1999, 42: 647-654.
  • 2Deepa R, Shanthi Rani S, Premalatha G, et al. Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians-the Chennai Urban Population Study. American Diabetes Association. Diabet Med, 2000, 17: 872-874.
  • 3Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga JC, et al. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care, 1998, 21: 1886-1888.
  • 4Wahl PW, Savage PJ, Psaty BM, et al. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet, 1998, 352: 1012-1015.
  • 5Burke JP, Haffner SM, Gaskill SP, et al. Reversion from type 2 diabetes to nondiabetic status. Influence of the 1997 American Diabetes Association criteria. Diabetes Care, 1998, 21: 1266-1270.
  • 6Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care, 1998, 21: 261-264.
  • 7Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the US population. Diabetes Care, 2000, 23: 187-191.
  • 8Wiener K, Roberts NB. The relative merits of haemoglobin A1c and fasting plasma glucose as first-line diagnostic tests for diabetes mellitus in non-pregnant subjects. Diabet Med, 1998, 15: 558-563.
  • 9Davidson MB, Schriger DL, Peters AL, et al. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA, 1999, 281: 1203-1210.
  • 10Anand SS, Razak F, Vuksan V, et al. Diagnostic strategies to detect glucose intolerance in a multiethnic Population. Diabetes Care, 2003, 26: 290-296.

共引文献156

同被引文献44

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部